Kunihisa Miwa

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:ResearchGate

Kunihisa Miwa, MD, PhD, (born January 21, 1950)[1] is a clinician and researcher in Internal Medicine, especially cardiology and cardiovascular physiology. He is the Director of Miwa Naika Clinic, Toyama, Japan.[2]

Dr. Miwa is one of the authors of the 2011 case definition for Myalgic encephalomyelitis called the International Consensus Criteria.[3]

Education[edit | edit source]

  • 1975, MD, Kyoto University, Japan[1]
  • 1983, PhD, Kyoto University, Japan[1]

Book chapters[edit | edit source]

Studies[edit | edit source]

Online presence[edit | edit source]

References[edit | edit source]

  1. 1.01.11.2 "Kunihisa Miwa". prabook.com. Retrieved May 25, 2020. 
  2. Carruthers, B. M.; van de Sande, M. I.; De Meirleir, K. L.; Klimas, N. G.; Broderick, G.; Mitchell, T.; Staines, D.; Powles, A. C. P.; Speight, N. (Oct 2011). "Myalgic encephalomyelitis: International Consensus Criteria: Review: ME: Intl. Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. PMC 3427890Freely accessible. PMID 21777306. 
  3. Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (Aug 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890Freely accessible. PMID 21777306. 
  4. Snell, Christopher R., ed. (Feb 15, 2012). An International Perspective on the Future of Research in Chronic Fatigue Syndrome. InTech. doi:10.5772/1460. ISBN 978-953-51-0072-0. 
  5. Miwa, Kunihisa; Fujita, Masatoshi (Jul 2008). "Small Heart Syndrome in Patients with Chronic Fatigue Syndrome". Clinical Cardiology. 31 (7): 328–333. doi:10.1002/clc.20227. PMC 6653127Freely accessible. PMID 18636530. 
  6. Miwa, Kunihisa; Fujita, Masatoshi (Aug 2009). "Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and "small heart"". Journal of Cardiology. 54 (1): 29–35. doi:10.1016/j.jjcc.2009.02.008. 
  7. Miwa, Kunihisa; Fujita, Masatoshi (2009), "Cardiovascular Dysfunction with Low Cardiac Output Due to a Small Heart in Patients with Chronic Fatigue Syndrome", Internal Medicine, 48 (21): 1849-1854, doi:10.2169/internalmedicine.48.2347, PMID 19881233 
  8. Miwa, Kunihisa; Fujita, Masatoshi (Dec 2011). "Small Heart With Low Cardiac Output for Orthostatic Intolerance in Patients With Chronic Fatigue Syndrome". Clinical Cardiology. 34 (12): 782–786. doi:10.1002/clc.20962. PMC 6652296Freely accessible. PMID 22120591. 
  9. Miwa, Kunihisa; Fujita, Masatoshi (Mar 2014). "Renin–aldosterone paradox in patients with myalgic encephalomyelitis and orthostatic intolerance". International Journal of Cardiology. 172 (2): 514–515. doi:10.1016/j.ijcard.2014.01.043. 
  10. Miwa, Kunihisa (Jul 2015). "Cardiac dysfunction and orthostatic intolerance in patients with myalgic encephalomyelitis and a small left ventricle". Heart and Vessels. 30 (4): 484–9. doi:10.1007/s00380-014-0510-y. 
  11. Miwa, Kunihisa (2016). "Variability of postural orthostatic tachycardia in patients with myalgic encephalomyelitis and orthostatic intolerance". Heart and Vessels. 31 (9): 1522–1528. doi:10.1007/s00380-015-0744-3. 
  12. Miwa, Kunihisa (Apr 2017). "Down-regulation of renin–aldosterone and antidiuretic hormone systems in patients with myalgic encephalomyelitis/chronic fatigue syndrome". Journal of Cardiology. 69 (4): 684–688. doi:10.1016/j.jjcc.2016.06.003. 
  13. Miwa, K (Oct 1, 2019). "P5344Paradigme shift to disequilibrium in the genesis of orthostatic intolerance in patients with chronic fatigue syndrome". European Heart Journal. 40 (Supplement_1): ehz746.0311. doi:10.1093/eurheartj/ehz746.0311. ISSN 0195-668X. 

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

orthostatic intolerance (OI) - The development of symptoms when standing upright, where symptoms are relieved upon reclining. Patients with orthostatic intolerance have trouble remaining upright for more than a few seconds or a few minutes, depending upon severity. In severe orthostatic intolerance, patients may not be able to sit upright in bed. Orthostatic intolerance is often a sign of dysautonomia. There are different types of orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS).

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.